In line with this evidence, our study results revealed that prenatal exposure to kisspeptin antagonist during the development of the HPO axis can prevent the appearance of PCOS phenotype (irregular sexual cycles, androgen excess, ovulation dysfunction, and ovarian cysts) in adulthood, despite exposure to androgens during fetal life. The gene discussed is KISS1; the disease is polycystic ovary syndrome.